Insider Buying: Diaceutics (LON:DXRX) Insider Purchases 117 Shares of Stock

Diaceutics PLC (LON:DXRX) insider Nick Roberts acquired 117 shares of the business’s stock in a transaction dated Tuesday, December 23rd. The stock was purchased at an average price of GBX 128 per share, with a total value of £149.76.

Nick Roberts also recently made the following trade(s):

• On Wednesday, October 1st, Nick Roberts acquired 91 shares of Diaceutics stock. The shares were purchased at an average price of GBX 165 per share, for a total transaction of £150.15.

Diaceutics Stock Performance

Shares of LON DXRX opened at GBX 126.61 on Tuesday. The stock’s 50-day moving average is GBX 153.61 and its 200 day moving average is GBX 142.38. The stock has a market cap of £107.14 million, a price-to-earnings ratio of -70.34 and a beta of 0.58. Diaceutics PLC has a 1-year low of GBX 106 and a 1-year high of GBX 168. The company has a current ratio of 4.85, a quick ratio of 9.92 and a debt-to-equity ratio of 0.39.

Diaceutics (LON:DXRX) last issued its quarterly earnings results on Tuesday, September 23rd. The company reported GBX (2.84) EPS for the quarter. Diaceutics had a negative net margin of 10.90% and a negative return on equity of 7.15%. On average, sell-side analysts anticipate that Diaceutics PLC will post 1.0107919 EPS for the current fiscal year.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.